You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Eosinophilia

Showing 1 - 25 of 826
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

Recruiting
  • IgG4-related Disease With Eosinophilia
  • Beijing, Bejing, China
    Peking Union Medical College Hospital
Mar 23, 2023

Activation and Function of Eosinophils in Conditions With Blood

Recruiting
  • Immune System Diseases
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    NSCLC Trial in Liège (induced sputum, lung biopsy, bronchoalveolar lavage)

    Recruiting
    • Non-small Cell Lung Cancer
    • induced sputum
    • +3 more
    • Liège, Belgium
      CHU de Liège
    Nov 7, 2022

    Chronic Rhinosinusitis With Nasal Polyps, Asthma; Eosinophilic, Eosinophilia Trial in Denmark (dupilumab, mepolizumab)

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • +2 more
    • dupilumab
    • mepolizumab
    • Aalborg, Denmark
    • +8 more
    Jul 3, 2023

    COPD, Eosinophilia Trial in Boston (Air purifier, Sham air purifier)

    Enrolling by invitation
    • COPD
    • Eosinophilia
    • Air purifier
    • Sham air purifier
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Nov 3, 2022

    Esophageal Distensibility With Proton Pump Inhibitors in

    Recruiting
    • Eosinophilic Esophagitis
    • endoflip
    • Indianapolis, Indiana
      Indiana University
    Feb 11, 2022

    Asthma; Eosinophilic Trial in Hamilton (Reslizumab)

    Recruiting
    • Asthma; Eosinophilic
    • Reslizumab
    • Hamilton, Ontario, Canada
      Firestone Institute of Respiratory Health, St Joseph's Hospital
    Mar 28, 2022

    Loiasis Trial run by the NIAID (Reslizumab, Diethylcarbamazine, Placebo)

    Completed
    Has Results
    • Loiasis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 20, 2022

    Chronic Obstructive Pulmonary Disease and Eosinophilia Among

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Minimal questionnaire
    • +5 more
    • Londrina, Paraná, Brazil
    • +3 more
    Apr 11, 2022

    Familial Hypereosinophilia: Natural History and Markers of

    Recruiting
    • Eosinophilia
    • Hypereosinophilic Syndrome
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Apr 7, 2022

      Severe Eosinophilic Asthma Phenotypes During Childhood Have

      Not yet recruiting
      • Severe Asthma
      • Asthma in Children
        • Paris, France
          Allergy Department, Trousseau Hospital
        Feb 28, 2023

        Eosinophilic Fasciitis Trial in Al ?ayy Ath Thamin (High-Intensity Laser Therapy)

        Recruiting
        • Eosinophilic Fasciitis
        • High-Intensity Laser Therapy
        • Al Ḩayy Ath Thāmin, Giza, Egypt
          Outpatient clinic of faculty of physical therapy, Ahram Canadian
        Jun 14, 2023

        Gene Transcription and Immunophenotypes Following Mepolizumab

        Active, not recruiting
        • Eosinophilic Asthma
          • Rochester, Minnesota
            Mayo Clinic in Rochester
          Jan 17, 2023

          Functional Dyspepsia Trial in Kansas City (Ketotifen, Placebo)

          Recruiting
          • Functional Dyspepsia
          • Kansas City, Missouri
            The Children's Mercy Hospital
          Oct 4, 2021

          Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

          Recruiting
          • Eosinophilic Myeloid Neoplasm
          • Hypereosinophilic Syndrome
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 25, 2023

          Bronchial Inflammation, Small Airways Disfunction and Mucous

          Not yet recruiting
          • Asthma; Eosinophilic
          • Dupilumab
          • (no location specified)
          Mar 15, 2023

          Eosinophilic Asthma Trial in Taipei (AD17002, Placebo)

          Not yet recruiting
          • Eosinophilic Asthma
          • Taipei, Taiwan
            Taipei Medical University Hospital
          Aug 16, 2023

          Patient-Reported OUTcomes of Benralizumab in Real-World Use in

          Not yet recruiting
          • Severe Asthma
            • (no location specified)
            Nov 17, 2022

            Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder Trial run by the NIAID (prednisone)

            Completed
            Has Results
            • Eosinophilia
            • +3 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Jan 26, 2022

            COPD Trial in Germany, United Kingdom (QAW039, Placebo)

            Terminated
            Has Results
            • Chronic Obstructive Pulmonary Disease
            • Frankfurt, Germany
            • +3 more
            Oct 7, 2021

            COPD, Eosinophilia Trial in Leicester (Mepolizumab, Placebo)

            Recruiting
            • COPD
            • Eosinophilia
            • Leicester, Leicestershire, United Kingdom
              NIHR Biomedical Research Centre, Respiratory
            Jan 28, 2022

            Mepolizumab and Physical Activity in Severe Asthma

            Not yet recruiting
            • Asthma
            • Asthma; Eosinophilic
              • (no location specified)
              May 31, 2022

              Gastrointestinal STRING Test With Oral Immunotherapy

              Enrolling by invitation
              • Eosinophilic Disorder
              • Food Allergy
              • Entero-tracker
              • Palo Alto, California
                Sean N Parker Center for Allergy and Asthma Research at Stanford
              Nov 21, 2022

              Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in Jacksonville (Dexpramipexole DiHCl, Placebo)

              Recruiting
              • Eosinophilic Asthma
              • +2 more
              • Dexpramipexole Dihydrochloride
              • Placebo
              • Jacksonville, Florida
                Research Site 30001-291
              Apr 17, 2023

              BCR-JAK2 Fusion Protein Expression, Blasts 20 Percent or Less of Peripheral Blood White Cells, Blasts More Than 5 Percent of

              Recruiting
              • BCR-JAK2 Fusion Protein Expression
              • +11 more
              • Palo Alto, California
              • +3 more
              Oct 5, 2022